Genmab partners with Incyte on metastatic colorectal cancer trial

GMAB•2026-10-24

Genmab entered a clinical trial collaboration with Incyte for a Phase 1/2 study testing petosemtamab with INCB161734 and chemotherapy as first-line treatment for KRAS G12D-mutated metastatic colorectal cancer. Incyte will co-fund the study and provide clinical supplies of INCB161734.

Genmab partners with Incyte on metastatic colorectal cancer trial

1. Trial collaboration

Related News

Zymeworks presents new phase 1 data for ZW191

Lilly presents first clinical data in platinum-sensitive ovarian cancer for investigational ADC

Cricut CEO Ashish Arora sells $1.13 million in common shares

Chainfir Capital says Visa reportedly bid $2.5 billion for Fireblocks, signaling reset in crypto valuations

Nasdaq halts trading in TWG pending news at 7:50 p.m.